Related Experiment Video
Updated: May 31, 2026

11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Biological outcome measurements for behavioral interventions in multiple sclerosis
Anja Fischer1, Christoph Heesen, Stefan M Gold
1Institute for Neuroimmunology and Clinical Multiple Sclerosis Research (inims), University Hospital Hamburg, Eppendorf, Germany.
Therapeutic Advances in Neurological Disorders
|July 19, 2011
Summary
Behavioral interventions for multiple sclerosis (MS) may impact underlying biology. Future research should combine behavioral and biological measures to assess treatment effects on MS pathology, focusing on depression and fatigue.
Area of Science:
- Neuroscience
- Psychology
- Rehabilitation Medicine
Background:
- Behavioral interventions like exercise and psychotherapy are increasingly used in multiple sclerosis (MS) care.
- Current research often focuses on psychosocial outcomes (quality of life, fatigue, depression).
- Neuropsychiatric symptoms in MS are linked to biological processes (inflammation, brain damage).
Purpose of the Study:
- To explore how behavioral interventions might influence MS pathology.
- To illustrate combining biological and psychological outcome measures for evaluating behavioral interventions.
- To focus on depression and fatigue as key targets for behavioral interventions in MS.
Main Methods:
- Reviewing existing scientific evaluations of behavioral interventions in MS.
- Identifying potential biological pathways affected by behavioral approaches.
- Proposing a framework for selecting appropriate behavioral and biological outcome measures.
Main Results:
- Behavioral interventions may influence biological processes underlying MS symptoms.
- A combined approach using biological and psychological outcomes is feasible for evaluating interventions.
- Depression and fatigue are promising targets for such interventions.
Conclusions:
- Behavioral interventions hold potential beyond psychosocial benefits, possibly impacting MS biology.
- Rigorous study designs integrating behavioral and biomarker data are crucial.
- Further research is needed to validate the biological effects of behavioral interventions for MS, particularly for depression and fatigue.

